189 related articles for article (PubMed ID: 35872575)
1. TRIM26 inhibits hepatitis B virus replication by promoting HBx degradation and TRIM26 genetic polymorphism predicts PegIFNα treatment response of HBeAg-positive chronic hepatitis B Patients.
Luo M; Hou J; Mai H; Chen J; Chen H; Zhou B; Hou J; Jiang DK
Aliment Pharmacol Ther; 2022 Sep; 56(5):878-889. PubMed ID: 35872575
[TBL] [Abstract][Full Text] [Related]
2. TRIM26 positively affects hepatitis B virus replication by inhibiting proteasome-dependent degradation of viral core protein.
Nakaya Y; Nishizawa T; Nishitsuji H; Morita H; Yamagata T; Onomura D; Murata K
Sci Rep; 2023 Aug; 13(1):13584. PubMed ID: 37604854
[TBL] [Abstract][Full Text] [Related]
3. A missense variant in complement factor B (CFB) is a potential predictor of 24-week off-treatment response to PegIFNα therapy in Chinese HBeAg-positive chronic hepatitis B patients.
Chen H; Sun J; Zhou B; Peng J; Xie Q; Liang X; Fan R; Conran C; Xu J; Ji Y; Zhang X; Sun L; Jia J; Wang G; Hou J; Jiang DK
Aliment Pharmacol Ther; 2020 Feb; 51(4):469-478. PubMed ID: 31943297
[TBL] [Abstract][Full Text] [Related]
4. Higher BST2 Expression Promotes the Anti-HBV Effect of IFN-α and BST2 Genetic Variant Predicts PegIFNα Treatment Response of HBeAg-Positive Chronic Hepatitis B Patients.
Chen J; Hou J; Na R; Zhou B; Hou J; Jiang DK
Clin Pharmacol Ther; 2024 Feb; 115(2):361-370. PubMed ID: 38018367
[TBL] [Abstract][Full Text] [Related]
5. Type-III interferon stimulated gene TRIM31 mutation in an HBV patient blocks its ability in promoting HBx degradation.
Xu F; Song H; Xiao Q; Wei Q; Pang X; Gao Y; Tan G
Virus Res; 2022 Jan; 308():198650. PubMed ID: 34863820
[TBL] [Abstract][Full Text] [Related]
6. CXCL13 variant predicts pegylated-interferon α treatment response in HBeAg-positive chronic hepatitis B patients.
Luo M; Zhang L; Yang C; Zhou B; Hou J; Jiang DK
J Med Virol; 2023 Jul; 95(7):e28963. PubMed ID: 37470204
[TBL] [Abstract][Full Text] [Related]
7. Type-I-IFN-Stimulated Gene TRIM5γ Inhibits HBV Replication by Promoting HBx Degradation.
Tan G; Yi Z; Song H; Xu F; Li F; Aliyari R; Zhang H; Du P; Ding Y; Niu J; Wang X; Su L; Qin FX; Cheng G
Cell Rep; 2019 Dec; 29(11):3551-3563.e3. PubMed ID: 31825835
[TBL] [Abstract][Full Text] [Related]
8. A genetic variant of
Luo M; Dong C; Liang X; Na R; Zhou B; Hou J; Jiang D-K
J Clin Microbiol; 2024 Feb; 62(2):e0139623. PubMed ID: 38259071
[TBL] [Abstract][Full Text] [Related]
9. PreS1BP mediates inhibition of Hepatitis B virus replication by promoting HBx protein degradation.
Wang J; Yuan X; Wang Y; Zhang Y; Han M; Lu H; Liu S; Zhang Y; Ge F; Liu Y; Cheng J
Virus Res; 2024 Mar; 341():199326. PubMed ID: 38253259
[TBL] [Abstract][Full Text] [Related]
10. TRIM25 inhibits HBV replication by promoting HBx degradation and the RIG-I-mediated pgRNA recognition.
Song H; Xiao Q; Xu F; Wei Q; Wang F; Tan G
Chin Med J (Engl); 2023 Apr; 136(7):799-806. PubMed ID: 36975005
[TBL] [Abstract][Full Text] [Related]
11. Dicoumarol, an NQO1 inhibitor, blocks cccDNA transcription by promoting degradation of HBx.
Cheng ST; Hu JL; Ren JH; Yu HB; Zhong S; Wai Wong VK; Kwan Law BY; Chen WX; Xu HM; Zhang ZZ; Cai XF; Hu Y; Zhang WL; Long QX; Ren F; Zhou HZ; Huang AL; Chen J
J Hepatol; 2021 Mar; 74(3):522-534. PubMed ID: 32987030
[TBL] [Abstract][Full Text] [Related]
12. E3 ubiquitin ligase TRIM21 restricts hepatitis B virus replication by targeting HBx for proteasomal degradation.
Song Y; Li M; Wang Y; Zhang H; Wei L; Xu W
Antiviral Res; 2021 Aug; 192():105107. PubMed ID: 34097931
[TBL] [Abstract][Full Text] [Related]
13. Hepatitis B Virus X Protein Promotes Degradation of SMC5/6 to Enhance HBV Replication.
Murphy CM; Xu Y; Li F; Nio K; Reszka-Blanco N; Li X; Wu Y; Yu Y; Xiong Y; Su L
Cell Rep; 2016 Sep; 16(11):2846-2854. PubMed ID: 27626656
[TBL] [Abstract][Full Text] [Related]
14. Hepatitis B virus X protein-elevated MSL2 modulates hepatitis B virus covalently closed circular DNA by inducing degradation of APOBEC3B to enhance hepatocarcinogenesis.
Gao Y; Feng J; Yang G; Zhang S; Liu Y; Bu Y; Sun M; Zhao M; Chen F; Zhang W; Ye L; Zhang X
Hepatology; 2017 Nov; 66(5):1413-1429. PubMed ID: 28608964
[TBL] [Abstract][Full Text] [Related]
15. Characterization of hepatitis B virus X gene quasispecies complexity in mono-infection and hepatitis delta virus superinfection.
Godoy C; Tabernero D; Sopena S; Gregori J; Cortese MF; González C; Casillas R; Yll M; Rando A; López-Martínez R; Quer J; González-Aseguinolaza G; Esteban R; Riveiro-Barciela M; Buti M; Rodríguez-Frías F
World J Gastroenterol; 2019 Apr; 25(13):1566-1579. PubMed ID: 30983817
[TBL] [Abstract][Full Text] [Related]
16. Hepatitis B virus X protein recruits methyltransferases to affect cotranscriptional N6-methyladenosine modification of viral/host RNAs.
Kim GW; Siddiqui A
Proc Natl Acad Sci U S A; 2021 Jan; 118(3):. PubMed ID: 33397803
[TBL] [Abstract][Full Text] [Related]
17. Hepatitis C virus core protein inhibits hepatitis B virus replication by downregulating HBx levels via Siah-1-mediated proteasomal degradation during coinfection.
Lee S; Yoon H; Han J; Jang KL
J Gen Virol; 2021 Dec; 102(12):. PubMed ID: 34882535
[TBL] [Abstract][Full Text] [Related]
18. Hepatitis B virus X gene impacts on the innate immunity and immune-tolerant phase in chronic hepatitis B virus infection.
Chang KC; Chua HH; Chen YH; Tsuei DJ; Lee MH; Chiang CL; Jeng YM; Wu JF; Chen HL; Hsu HY; Ni YH; Chang MH
Liver Int; 2022 Oct; 42(10):2154-2166. PubMed ID: 35762289
[TBL] [Abstract][Full Text] [Related]
19. Peroxiredoxin 1, a Novel HBx-Interacting Protein, Interacts with Exosome Component 5 and Negatively Regulates Hepatitis B Virus (HBV) Propagation through Degradation of HBV RNA.
Deng L; Gan X; Ito M; Chen M; Aly HH; Matsui C; Abe T; Watashi K; Wakita T; Suzuki T; Okamoto T; Matsuura Y; Mizokami M; Shoji I; Hotta H
J Virol; 2019 Mar; 93(6):. PubMed ID: 30567989
[TBL] [Abstract][Full Text] [Related]
20. Taurocholic acid inhibits the response to interferon-α therapy in patients with HBeAg-positive chronic hepatitis B by impairing CD8
Xun Z; Lin J; Yu Q; Liu C; Huang J; Shang H; Guo J; Ye Y; Wu W; Zeng Y; Wu S; Xu S; Chen T; Chen J; Ou Q
Cell Mol Immunol; 2021 Feb; 18(2):461-471. PubMed ID: 33432062
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
